Part IV In Vitro Diagnostic Medical Devices
United Kingdom
- 32Interpretation of Part IV
- 33Scope of Part IV
- 33ARegistration etc. of persons placing in vitro diagnostic medical devices on the market
- 34Essential requirements for in vitro diagnostic medical devices
- 34AApproval requirement for coronavirus test devices
- 34BPublic sector use of coronavirus test devices
- 34CTransitional provisions for coronavirus test devices
- 34DExemption for coronavirus test devices in conformity with Regulation (EU) 2017/746 and Regulation (EU) 2022/1107
- 35Determining compliance of in vitro diagnostic medical devices with relevant essential requirements
- 36UK marking of in vitro diagnostic medical devices
- 36AUK(NI) indication: in vitro diagnostic medical devices
- 37UK marking of in vitro diagnostic devices that come within the scope of this Part and other legislation
- 38In vitro diagnostic medical devices not ready for use
- 38AApplications for approval of coronavirus test devices
- 38BPerformance requirements for coronavirus test devices
- 38CRegister of approved coronavirus test devices
- 39Exemptions from this Part
- 39AExemptions for coronavirus test devices
- 40Procedures for affixing a UK marking to in vitro diagnostic medical devices
- 41Manufacturers etc. and conformity assessment procedures for in vitro diagnostic medical devices
- 42Approved bodies and the conformity assessment procedures for in vitro diagnostic medical devices
- 43Devices for performance evaluation
- 44Registration of persons placing in vitro diagnostic medical devices on the market or for performance evaluation
- 44ZAObligations in Part IV which are met by complying with obligations in Directive 98/79
- 44ZBObligations in Part IV of these Regulations which are met by complying with obligations in Regulation (EU) 2017/746